Regent Investment Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | $1.51M | Sell |
4,130
-50
| -1% | -$17.7K | 0.4% | 68 |
|
|
2022
Q3 | $1.35M | Hold |
4,180
| – | – | 0.39% | 71 |
|
|
2022
Q2 | $1.35M | Sell |
4,180
-150
| -3% | -$45K | 0.38% | 69 |
|
|
2022
Q1 | $1.24M | Hold |
4,330
| – | – | 0.29% | 87 |
|
|
2021
Q4 | $1.2M | Buy |
4,330
+150
| +4% | +$38K | 0.26% | 94 |
|
|
2021
Q3 | $966K | Hold |
4,180
| – | – | 0.23% | 99 |
|
|
2021
Q2 | $960K | Buy |
4,180
+181
| +5% | +$36.4K | 0.23% | 100 |
|
|
2021
Q1 | $747K | Hold |
3,999
| – | – | 0.19% | 105 |
|
|
2020
Q4 | $675K | Hold |
3,999
| – | – | 0.19% | 103 |
|
|
2020
Q3 | $592K | Hold |
3,999
| – | – | 0.18% | 105 |
|
|
2020
Q2 | $656K | Sell |
3,999
-934
| -19% | -$143K | 0.22% | 97 |
|
|
2020
Q1 | $685K | Sell |
4,933
-300
| -6% | -$41.2K | 0.28% | 79 |
|
|
2019
Q4 | $688K | Hold |
5,233
| – | – | 0.21% | 115 |
|
|
2019
Q3 | $585K | Hold |
5,233
| – | – | 0.19% | 121 |
|
|
2019
Q2 | $579K | Buy |
5,233
+1,000
| +24% | +$118K | 0.19% | 126 |
|
|
2019
Q1 | $550K | Sell |
4,233
-135
| -3% | -$16.4K | 0.18% | 126 |
|
|
2018
Q4 | $506K | Buy |
4,368
+1,000
| +30% | +$112K | 0.19% | 128 |
|
|
2018
Q3 | $361K | Hold |
3,368
| – | – | 0.11% | 155 |
|
|
2018
Q2 | $288K | Sell |
3,368
-100
| -3% | -$8.21K | 0.1% | 169 |
|
|
2018
Q1 | $269K | Sell |
3,468
-75
| -2% | -$6.04K | 0.09% | 181 |
|
|
2017
Q4 | $299K | Hold |
3,543
| – | – | 0.1% | 173 |
|
|
2017
Q3 | $303K | Sell |
3,543
-60
| -2% | -$4.92K | 0.1% | 167 |
|
|
2017
Q2 | $297K | Hold |
3,603
| – | – | 0.1% | 174 |
|
|
2017
Q1 | $303K | Sell |
3,603
-200
| -5% | -$16K | 0.11% | 165 |
|
|
2016
Q4 | $280K | Sell |
3,803
-400
| -10% | -$29.8K | 0.14% | 157 |
|
|
2016
Q3 | $337K | Sell |
4,203
-150
| -3% | -$12K | 0.18% | 136 |
|
|
2016
Q2 | $342K | Sell |
4,353
-100
| -2% | -$7.53K | 0.19% | 130 |
|
|
2016
Q1 | $321K | Sell |
4,453
-75
| -2% | -$5.67K | 0.18% | 135 |
|
|
2015
Q4 | $382K | Hold |
4,528
| – | – | 0.2% | 127 |
|
|
2015
Q3 | $379K | Buy |
4,528
+653
| +17% | +$55.1K | 0.21% | 125 |
|
|
2015
Q2 | $324K | Sell |
3,875
-3,100
| -44% | -$236K | 0.16% | 141 |
|
|
2015
Q1 | $507K | Sell |
6,975
-7,080
| -50% | -$504K | 0.26% | 111 |
|
|
2014
Q4 | $970K | Hold |
14,055
| – | – | 0.5% | 61 |
|
|
2014
Q3 | $911K | Sell |
14,055
-350
| -2% | -$22.2K | 0.47% | 69 |
|
|
2014
Q2 | $896K | Buy |
14,405
+775
| +6% | +$46.2K | 0.44% | 76 |
|
|
2014
Q1 | $802K | Buy |
+13,630
| New | +$761K | 0.42% | 75 |
|
Other funds holding LLY
Regent Investment Management's LLY Position: Q4 2022 in Review
Regent Investment Management reduced its Eli Lilly (LLY) stake by 1.2% in Q4 2022, selling an estimated $17.7K and leaving 4,130 shares worth $1.51M. The position accounts for 0.4% of the portfolio, ranked #68.
Regent Investment Management first reported a position in LLY in Q1 2014 and has held it in 36 quarters since. 2,671 funds tracked by Wall St. Rank hold LLY as of Q4 2022.
- Regent Investment Management held 4,130 shares of Eli Lilly worth $1.51M as of Q4 2022.
- Regent Investment Management sold 50 Eli Lilly shares in Q4 2022, an estimated $17.7K.
- Eli Lilly made up 0.4% of Regent Investment Management's portfolio in Q4 2022, its #68 holding.
- Regent Investment Management first reported a position in Eli Lilly in Q1 2014 and has held it in 36 quarters since.
- 2,671 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2022.
Based on Regent Investment Management's 13F filing for Q4 2022, filed 26 Jan 2023.